Glen Eagle Advisors, LLC Ampio Pharmaceuticals, Inc. Transaction History

Glen Eagle Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.11 - $0.92 $110 - $920	-1,000 Closed	0 $0
Q4 2022 Aug 13, 2024	SELL	$0.03 - $18.0 $30 - $18,000	-1,000 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$0.75 - $2.76 $750 - $2,760	1,000 New	1,000 $1.59 Million
Q1 2019 Aug 13, 2024	BUY	$0.43 - $0.68 $430 - $680	1,000 New	1,000 $562,000
Q2 2018 Aug 13, 2024	SELL	$1.66 - $3.82 $3,984 - $9,168	-2,400 Reduced 70.59%	1,000 $2.2 Million
Q1 2018 Aug 14, 2024	BUY	$2.16 - $3.48 $2,160 - $3,480	1,000 New	1,000 $3.4 Million
Q1 2018 Aug 13, 2024	BUY	$2.16 - $3.48 $5,184 - $8,352	2,400 Added 240.0%	3,400 $3.4 Million
Q4 2017 Aug 13, 2024	BUY	$0.68 - $4.19 $680 - $4,190	1,000	1,000 $4.07 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.